AngioDynamics reported $-4.41M in Net Income for its fiscal quarter ending in February of 2025.





Net Income Change Date
AngioDynamics USD -4.41M 6.33M Feb/2025
AtriCure USD -267K 5.92M Sep/2025
Boston Scientific USD 672M 83M Dec/2025
Edwards Lifesciences USD 91.2M 199.9M Dec/2025
ICU Medical USD -3.4M 38.73M Sep/2025
Inogen USD -5.96M 373K Sep/2024
J&J USD 5.12B 36M Dec/2025
Medtronic USD 1.37B 334M Sep/2025
Merit Medical Systems USD 27.76M 4.83M Sep/2025
Mesa Laboratories USD -1.68M 5.1M Dec/2024
Orthofix International USD -126M 98.61M Dec/2024
Smiths GBP 168M 57M Dec/2025
Surmodics USD -11.54M 3.99M Sep/2024
Tandem Diabetes Care USD -21.16M 31.24M Sep/2025
Teleflex USD -408.89M 531.47M Sep/2025
Terumo JPY 35.05B 6.79B Sep/2025
Trinity Biotech USD -5.14M 11.82M Sep/2025